U.S. businesses increasingly are coming under scrutiny from antitrust regulators across the Atlantic. At the European Commission alone, cases have been filed or are pending against leading technology firms--including Intel, Qualcomm, Apple, Rambus, and Microsoft--as well as some of the most successful pharmaceutical companies such as Pfizer and Merck. Does international regulation of U.S. business undermine American economic sovereignty? Or are U.S. regulators equally enthusiastic about micromanaging foreign business? What are the broader implications for international trade?
At this AEI event, speakers will weigh the impact of international antitrust regulation and debate the wisdom and necessity of U.S. action to protect American business and strengthen the foundations of free trade. A panel discussion will feature Thomas O. Barnett, assistant attorney general for antitrust at the Department of Justice; Randolph W. Tritell, director of international affairs at the Federal Trade Commission; and international antitrust expert Theodore W. Ullyot of Kirkland & Ellis LLP. AEI’s John G. Searle Scholar, Michael S. Greve, will moderate.








